PX1 Research provides academic and corporate laboratories with analytical-grade Chonluten (Glu-Asp-Gly) synthetic tripeptide manufactured to rigorous quality control standards. Each synthesis lot undergoes complete third-party validation via high-performance liquid chromatography, mass spectrometry, and endotoxin analysis to ensure reproducible experimental results in cell culture and animal tissue models.
PX1 Research provides academic and corporate laboratories with analytical-grade Chonluten (Glu-Asp-Gly) synthetic tripeptide manufactured to rigorous quality control standards. Each synthesis lot undergoes complete third-party validation via high-performance liquid chromatography, mass spectrometry, and endotoxin analysis to ensure reproducible experimental results in cell culture and animal tissue models.
Evaluating an anti-inflammatory Chonluten professional manufacturer requires verifying that the supplier maintains strict analytical oversight, documented chain-of-custody, and domestic synthesis facilities. PX1 Research manufactures high-purity Chonluten (EDG tripeptide) in US-based, GMP-compliant facilities under ISO 17025 testing protocols to support advanced in vitro and preclinical research into peptide-driven cellular regulation.
When purchasing raw peptide materials for controlled assay environments, researchers require batch-specific verification rather than generic certificates of analysis. PX1 Research validates every lot of Chonluten tripeptide through independent third-party laboratories, supplying comprehensive mass spectra and RP-HPLC chromatograms showing purity levels exceeding 98.0%. This commitment to chemical transparency eliminates confounding variables caused by residual solvents, counter-ions, or peptide fragments.
Chonluten is a synthetic tripeptide consisting of the amino acid sequence L-glutamic acid, L-aspartic acid, and L-glycine (H-Glu-Asp-Gly-OH). Classified within the Khavinson short-chain peptide family, this low-molecular-weight compound (molecular weight approx. 319.27 g/mol) is engineered to study direct peptide-chromatin interactions within cell nuclei.
Due to its short sequence and negative net charge at physiological pH, Chonluten serves as an ideal structural molecule for evaluating sequence-specific DNA binding. Researchers frequently investigate how short peptides penetrate cell and nuclear membranes without requiring specialized transporter proteins, facilitating direct study of gene expression modulation in respiratory epithelial cultures and connective tissue assays. For broader studies involving bioregulatory chains, laboratories often cross-reference data from our short-chain bioregulator peptides library.
In vitro and animal models suggest that Chonluten interacts with specific histones and promoter regions of DNA to modulate localized inflammatory responses. In preclinical models of induced pulmonary inflammation, research indicates that administration of Chonluten alters the expression of key pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6).
Cellular assays demonstrate that Chonluten may influence nuclear factor kappa B (NF-κB) signaling cascades, reducing downstream transcription of inflammatory mediators in bronchial epithelial tissues. Studies examining oxidative stress markers indicate that cells pre-treated with Glu-Asp-Gly exhibit lower levels of reactive oxygen species (ROS) and preserved superoxide dismutase (SOD) activity when exposed to lipopolysaccharide (LPS) challenges. Laboratory investigators utilize these models to understand how small peptide motifs restore homeostasis within damaged or stressed mucosal barriers.
Published preclinical literature has extensively investigated Chonluten in rodent models of acute lung injury and chronic bronchial inflammation. In these studies, researchers observed marked reductions in leukocyte infiltration, bronchoalveolar lavage fluid (BALF) protein concentrations, and structural tissue remodeling following peptide exposure. This data highlights the utility of Chonluten as a reference compound for pulmonary pathobiology.
In addition to airway epithelial studies, ongoing work published in the PX1 research portal highlights how short-chain tripeptides alter chromatin condensation states. By modulating the accessibility of RNA polymerase to specific promoter sites, Chonluten appears to stimulate endogenous protein synthesis in senescent or damaged fibroblast cell lines. Researchers aiming to compare general tissue-repair mechanisms often contrast these nuclear pathways with extracellular signaling peptides like BPC-157 or tissue-remodeling complexes like GHK-Cu.
When designing comparative assays for tissue-specific gene regulation or anti-inflammatory response, selection of the appropriate control and test peptides is critical. Chonluten (Glu-Asp-Gly) target pathways overlap with several other low-molecular-weight short-chain peptides, yet exhibit distinct tissue specificity in literature.
For instance, while Chonluten is primarily utilized in bronchial and respiratory epithelial models, Bronchogen (Ala-Glu-Asp-Leu) targets overlapping pulmonary target pathways but features a tetrapeptide sequence with different binding affinities. Similarly, researchers evaluating vascular or endothelial inflammatory markers may select Vilon (Lys-Glu) or systemic cytoprotective compounds like KPV tripeptide. Evaluating these compounds side-by-side allows laboratories to map precise structure-activity relationships across various cell types.
For an anti-inflammatory Chonluten professional manufacturer, delivering raw material purity is paramount. Impurities such as truncated peptide sequences, trifluoroacetate (TFA) salts, and bacterial endotoxins can activate toll-like receptors (TLRs) in cell cultures, completely invalidating anti-inflammatory assay data.
PX1 Research enforces strict quality assurance protocols for every batch of Chonluten manufactured:
• High-Performance Liquid Chromatography (RP-HPLC): Confirms chemical purity ≥98.0%, ensuring minimal residual synthesis side-products. • Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact monoisotopic mass and structural sequence identity. • Limulus Amebocyte Lysate (LAL) Endotoxin Testing: Guarantees endotoxin levels remain below strictly controlled thresholds (<0.01 EU/mg), eliminating false-positive inflammatory responses in cell cultures. • Residual Solvent Analysis: Validates the complete removal of processing chemicals like acetonitrile and piperidine.
Chonluten is supplied by PX1 Research as a lyophilized (freeze-dried) powder to maximize chemical stability during transport and storage. Proper handling protocols must be observed to prevent enzymatic degradation or mechanical shear stress during preparation.
For reconstituting Chonluten in laboratory settings, sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4) is typically recommended depending on the final assay requirements. Researchers can utilize our online peptide reconstitution calculator to determine precise solvent volumes for target molar concentrations. Once reconstituted, stock solutions should be aliquoted into single-use microcentrifuge tubes to avoid repeated freeze-thaw cycles and stored at -20°C or -80°C for long-term stability.
PX1 Research operates dedicated manufacturing and distribution hubs in California and Arizona, allowing us to maintain complete oversight of the production pipeline. Orders placed by research facilities are fulfilled with same-day dispatch (Monday through Friday), minimizing thermal exposure and transit delays.
Academic institutions, biotechnology firms, and contract research organizations (CROs) requiring multi-gram quantities or custom synthesis specifications can access dedicated support through our wholesale lab account portal. All bulk shipments include lot-traceable documentation, batch-matched COAs, and direct access to our technical support team for analytical verification.
What is Chonluten and what is its primary sequence?
Chonluten is a synthetic bioregulatory tripeptide composed of L-glutamic acid, L-aspartic acid, and L-glycine (Glu-Asp-Gly). It is synthesized for laboratory research to study gene expression and tissue-specific cellular regulation.
How does PX1 Research verify the purity of Chonluten?
Every lot of Chonluten undergoes independent third-party analysis using RP-HPLC to verify chromatographic purity (≥98%) and ESI-MS to confirm exact molecular weight. Certificates of Analysis (COAs) are publicly accessible for every lot.
What endotoxin controls are implemented for Chonluten production?
PX1 Research conducts LAL (Limulus Amebocyte Lysate) testing on all Chonluten batches to ensure endotoxin levels are strictly controlled (<0.01 EU/mg), preventing unwanted immune activation in cell culture assays.
What preclinical models utilize Chonluten in published literature?
Literature documents the use of Chonluten primarily in cell cultures (bronchial epithelial cells, fibroblasts) and rodent models of pulmonary inflammation, acute respiratory distress, and oxidative tissue stress.
How should lyophilized Chonluten be stored upon arrival?
Lyophilized Chonluten powder should be stored at -20°C in a dry, dark environment. Desiccated storage protects the peptide from moisture absorption and peptide bond hydrolysis.
What solvent is recommended for reconstituting Chonluten for in vitro assays?
Depending on the experimental protocol, Chonluten dissolves readily in sterile cell-culture grade water, standard saline, or phosphate-buffered saline (PBS, pH 7.4).
How does Chonluten differ from Bronchogen?
Chonluten is a tripeptide (Glu-Asp-Gly), whereas Bronchogen is a tetrapeptide (Ala-Glu-Asp-Leu). While both are investigated for pulmonary tissue interactions, their distinct structures yield different target binding kinetics in preclinical assays.
Does PX1 Research supply Chonluten for human clinical use?
No. All products manufactured by PX1 Research, including Chonluten, are strictly intended for laboratory research and in vitro experimentation only. They are not for human or animal therapeutic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.